Abrogation of PIK3CA or PIK3R1 reduces proliferation, migration, and invasion in glioblastoma multiforme cells

被引:1
|
作者
Weber, Genevieve L. [1 ]
Parat, Marie-Odile [2 ]
Binder, Zev A. [1 ]
Gallia, Gary L. [1 ]
Riggins, Gregory J. [1 ]
机构
[1] Johns Hopkins Univ, Sch Med, Dept Neurosurg, Ludwig Collaborat Lab, Baltimore, MD 21205 USA
[2] Univ Queensland, Sch Pharm, Brisbane, Qld 4072, Australia
关键词
glioblastoma; PIK3CA; PIK3R1; invasion; PI3K; pathway analysis; FOCAL ADHESION KINASE; TUMOR-INDUCED ANGIOGENESIS; MALIGNANT GLIOMA-CELLS; PHOSPHATIDYLINOSITOL 3'-KINASE; REGULATORY SUBUNIT; P85; SUBUNIT; CATALYTIC SUBUNIT; SOMATIC MUTATIONS; DOWN-REGULATION; HIGH-FREQUENCY;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Glioblastoma multiforme (GBM) is a highly invasive and deadly brain tumor. Tumor cell invasion makes complete surgical resection impossible and reduces the efficacy of other therapies. Genome-wide analyses of mutations, copy-number changes, and expression patterns have provided new insights into genetic abnormalities common in GBM. We analyzed published data and identified the invasion and motility pathways most frequently altered in GBM. These were most notably the focal adhesion and integrin signaling, and extracellular matrix interactions pathways. We mapped alterations in each of these pathways and found that they included the catalytic PIK3CA and regulatory PIK3R1 subunit genes of the class IA PI3K. Knockdown of either of these genes separately in GBM cell lines by lentiviral-mediated shRNA expression resulted in decreased proliferation, migration, and invasion in all lines tested. FAK activity was reduced by knockdown of either PIK3CA or PIK3R1, and MMP2 levels were reduced by knockdown of PIK3R1. We conclude that PIK3R1, like PIK3CA, is a potential therapeutic target in GBM and that it also influences tumor cell growth and motility.
引用
收藏
页码:833 / 849
页数:17
相关论文
共 50 条
  • [41] PIK3CA mutations in gallbladder cancers
    Shigematsu, Hisayuki
    Takahashi, Takao
    Minna, John D.
    Gazdar, Adi F.
    Wistuba, Ignacio I.
    CANCER RESEARCH, 2006, 66 (08)
  • [42] PIK3CA mutations in vascular malformations
    Castillo, Sandra D.
    Baselga, Eulalia
    Graupera, Mariona
    CURRENT OPINION IN HEMATOLOGY, 2019, 26 (03) : 170 - 178
  • [43] PIK3CA mutations in cutaneous melanoma
    Omholt, Katarina
    Krockel, Doris
    Hansson, Johan
    CANCER RESEARCH, 2006, 66 (08)
  • [44] Mutations in PIK3CA are infrequent in neuroblastoma
    Dam, Vincent
    Morgan, Brian T.
    Mazanek, Pavel
    Hogarty, Michael D.
    BMC CANCER, 2006, 6 (1)
  • [45] PIK3CA Mutation Detection by Pyrosequencing
    Baker, C.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2010, 12 (06): : 902 - 902
  • [46] PIK3CA as an oncogene in cervical cancer
    Ma, YY
    Wei, SJ
    Lin, YC
    Lung, JC
    Chang, TC
    Whang-Peng, J
    Liu, JM
    Yang, DM
    Yang, WK
    Shen, CY
    ONCOGENE, 2000, 19 (23) : 2739 - 2744
  • [47] The Effect of Cyclosporin A Via P53, MDM2 and PIK3CA Gene Expressions in Glioblastoma Multiforme Cells
    Biray Avci, Cigir
    Dogan, Zeynep Ozlem
    Oktar, Nezih
    Dalbasti, Tayfun
    Yilmaz, Sunde
    Numanoglu, Sinem
    Akalin, Taner
    Gunduz, Cumhur
    JOURNAL OF NEUROLOGICAL SCIENCES-TURKISH, 2010, 27 (02): : 170 - 177
  • [48] Rare mutation of PIK3CA in meningiomas
    Jesse Chung-sean Pang
    Nellie Yuk Fei Chung
    Norman Hok Ling Chan
    Wai Sang Poon
    Teresa Thomas
    Ho-keung Ng
    Acta Neuropathologica, 2006, 111 : 284 - 285
  • [49] PIK3CA mutations in oligodendroglial tumours
    Hartmann, C
    Devermann, L
    Gehlhaar, C
    Holtkamp, N
    von Deimling, A
    NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY, 2006, 32 (02) : 209 - 212
  • [50] PIK3CA as an oncogene in cervical cancer
    Yen-Ying Ma
    Sung-Jen Wei
    Yu-Chen Lin
    Jia-Chyi Lung
    Ting-Chang Chang
    Jacqueline Whang-Peng
    Jacqueline M Liu
    Deng-Mei Yang
    Wen K Yang
    Chen-Yang Shen
    Oncogene, 2000, 19 : 2739 - 2744